EFG Capital International’s Rocket Pharmaceuticals RCKT Stock Holding History

EFG Capital International’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$233K	Buy	+11,711	New	+$237K	0.05%	134

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

EFG Capital International's RCKT Position: Q2 2023 in Review

EFG Capital International opened a new position in Rocket Pharmaceuticals (RCKT) in Q2 2023: 11,711 shares worth $233K. The stake represents 0.05% of the portfolio and ranks #134 among its holdings.

164 funds tracked by Wall St. Rank hold RCKT as of Q2 2023.

EFG Capital International held 11,711 shares of Rocket Pharmaceuticals worth $233K as of Q2 2023.
Rocket Pharmaceuticals was a new EFG Capital International position in Q2 2023.
Rocket Pharmaceuticals made up 0.05% of EFG Capital International's portfolio in Q2 2023, its #134 holding.
164 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2023.

Based on EFG Capital International's 13F filing for Q2 2023, filed 2 Aug 2023.